secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nuo Therapeutics, Inc. (AURX)
CIK:        0001091596
Form:       8-K
Filed at:   2022-08-30T23:59:59+00:00
Accession:  0001437749-22-021470
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nuo Therapeutics secures $500K equity investment from distributor Pacific Medical; raises $4.5M YTD
--------------------------------------------------------------------------------

- PacMed invests $500K for 500K shares at $1.00; receives two warrants for up to 450K shares tied to sales quotas.
- PacMed can earn up to 300K milestone shares if cumulative sales reach $4.5M–$12.5M over 2024–2025 periods.
- Company raised ~$4.5M in working capital equity in 2022, including this deal, to support Aurix commercial re-launch.
- Distribution network covers ~30% of U.S. population via 10 entities; PacMed contributes over 40 sales representatives.
- Stock approved for OTCQB trading; uplisting to national securities exchange considered as a future option.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1091596/000143774922021470/0001437749-22-021470-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1091596/000143774922021470/aurx20220824b_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-22-021470

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer